Barriers and Facilitators of HIV Care Engagement: Results of a Qualitative Study in St. Petersburg, Russia

AIDS and Behavior
Anna KuznetsovaAnastasia G Amirkhanian

Abstract

Russia has a large HIV epidemic, but medical care engagement is low. Eighty HIV-positive persons in St. Petersburg completed in-depth interviews to identify barriers and facilitators of medical HIV care engagement. The most commonly-reported barriers involved difficulties accessing care providers, dissatisfaction with the quality of services, and negative attitudes of provider staff. Other barriers included not having illness symptoms, life stresses, low value placed on health, internalized stigma and wanting to hide one's HIV status, fears of learning about one's true health status, and substance abuse. Care facilitators were feeling responsible for one's health and one's family, care-related support from other HIV-positive persons, and the onset of health decline and fear of death. Substance use remission facilitated care engagement, as did good communication from providers and trust in one's doctor. Interventions are needed in Russia to address HIV care infrastructural barriers and integrate HIV, substance abuse, care, and psychosocial services.

References

Mar 1, 1991·ANS. Advances in Nursing Science·J M Hall, P E Stevens
Apr 1, 1986·ANS. Advances in Nursing Science·M Sandelowski
Jun 1, 1995·Aging : Clinical and Experimental Research·A Lowenstein, Y Brick
Mar 8, 2005·AIDS·Lytt I GardnerUNKNOWN Antiretroviral Treatment and Access Study Study Group
Sep 5, 2007·AIDS and Behavior·Angela A AidalaAnne Siegler
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Carl W Dieffenbach, Anthony S Fauci
Sep 17, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Manya MagnusUNKNOWN YMSM of color Special Projects of National Significance Initiative Study Group
Nov 13, 2009·HIV Clinical Trials·Thomas P GiordanoRobert O Morgan
Nov 4, 2010·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Amy NunnCurt Beckwith
Dec 15, 2010·AIDS Research and Human Retroviruses·Avnish TripathiWayne A Duffus
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kenneth Hugh Mayer
Mar 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward M GardnerWilliam J Burman
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Dec 14, 2011·AIDS Care·Jennifer L FaganUNKNOWN Never In Care Project
Oct 30, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Laurie J BaumanDana Watnick
Feb 5, 2014·Journal of the International Association of Providers of AIDS Care·Ellen M TedaldiUNKNOWN HOPS Investigators
Feb 11, 2014·The Journal of the Association of Nurses in AIDS Care : JANAC·J Daniel KellyThomas P Giordano
Apr 9, 2014·International Journal for Equity in Health·Courtenay Sprague, Sara E Simon
Apr 23, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Chinazo O CunninghamBruce D Agins
May 20, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lytt I GardnerUNKNOWN Retention in Care Study Group
Jul 18, 2014·American Journal of Public Health·Lucia V TorianEllen W Wiewel
Nov 14, 2014·Journal of the International AIDS Society·Vadim Pokrovskiy
Nov 14, 2014·Journal of the International AIDS Society·Anastasia PokrovskayaOleg Yurin
Nov 14, 2014·Journal of the International AIDS Society·Alice RaymondAnton Pozniak

❮ Previous
Next ❯

Citations

Jan 22, 2017·Substance Abuse Treatment, Prevention, and Policy·Bulat IdrisovDonald Shepard
Jul 31, 2019·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Yuri A AmirkhanianTimothy L McAuliffe
Jun 22, 2017·AIDS and Behavior·E Jennifer EdelmanJeffrey H Samet
Sep 21, 2020·European Journal of Public Health·Elizabeth J KingJulia Godunova
Jun 20, 2020·Inflammatory Bowel Diseases·Ling GuoFrancis A Farraye

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.